Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Novo Integrated Sciences, Inc.

< Previous 1 2 Next >
Acenzia Selected to join Team Canada Trade Mission to India
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ IoNovo Iodine Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences and Farm 7 Group Announce Joint Venture for Kenya Cooperative Agricultural Project
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Reports Fiscal Year 2023 Third Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Reports Fiscal Year 2023 Second Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Receives $40,000,000 Commitment to Develop Eldercare Facilities in Canada
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Reports Fiscal Year 2023 First Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Embracing Technology and Innovation “Key” to Easing Healthcare Crisis
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public Offering
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
Novo Integrated Sciences’ IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada
From Novo Integrated Sciences, Inc.
Via Business Wire
Tickers NVOS
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.